Wales first to adopt new cervical screening technology

Thursday, 22 December 2011
Cervical Screening Wales will become the first screening programme in the UK to adopt new automated technology.
The programme, part of Public Health Wales, will implement the technology across Wales from 1 January 2012 following the publication of National Health Service Cancer Screening Programmes guidelines for its use.
BD FocalPoint technology is produced by the company Source BioScience and is the only automated technology for cervical cancer screening approved for use by the NHS.
It is able to analyse and identify up to 25 per cent of screening samples that can be reported as "all clear", requiring no manual examination.
With more than 200,000 tests undertaken across Wales during 2010/11, this represents a significant reduction in laboratory workload and will also help laboratories achieve the mandatory 14-day screening deadline for results under the Department of Health's Cancer Reform Strategy.
Bryan Rose, Head of Programme for Cervical Screening Wales said: "We are pleased to be the first service to formally adopt the BD FocalPoint system.
“CSW has run an independent assessment of the technology, which has led us to recognise for some time the benefits of using automated imaging for cervical screening.
“The technology will assist our laboratories to improve turnaround times within our defined standards and enhance the quality of service that we provide for women in Wales."
For more information on Cervical Screening Wales, visit: